Financials

Discussions Technicals Seasonals

373110 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to XCELL THERAPEUTICS INC. operating, investing, and financing activities

373110 free cash flow for Q4 24 is -1.66 B KRW. For 2024, 373110 free cash flow was -7.38 B KRW and operating cash flow was -7 B KRW.

Q1 '23

Q2 '23

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q1 '23

Q2 '23

Q3 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—